Drug Deal Disclosure Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Drug Deal Disclosure Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Labor.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Drug Deal Disclosure Act.
- Section ID7f910e8695ba41c7982f492ab4966f72: 2. Release of information relating to most-favored-nation pricing agreements Not later than 30 days after the date of enactment of this Act, the Secretary of...
- Section idc7da4dd180424baeaa4fb5c86fde4936: 3. Report to Congress Not later than 15 days after the completion of the release of agreements listed under section 2(a)(2), the Secretary shall submit to the...
- Section id0fbee00ca53f4548b5765c92027b9aad: 4. Congressional Budget Office and Government Accountability Office analysis Not later than 90 days after the completion of the release of agreements listed...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Drug Deal Disclosure Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Labor
Primary Purpose
This bill, Drug Deal Disclosure Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeIntroduced in Senate
Read twice and referred to the Committee on Health, Education, …
Mr. Wyden (for himself, Mr. Welch, Ms. Warren, Mr. Gallego, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology